Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154214 · ClinicalTrials.gov registry record
Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 30
- Enrollment target
NCT05154214 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 30 participants.
The verdict
NCT05154214 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively compare the effectiveness of a novel personalized approach to the surgical treatment of obstructive sleep apnea (OSA) in children, drug induced sleep endoscopy (DISE) directed surgery versus the standard adenotonsillectomy (AT). This will also serve to test the feasibility of recruiting families for a future randomized protocol comparing the same surgical techniques. It is the investigators' central hypothesis that a personalized DISE-directed surgical approach that uses existing procedures to address the specific fixed and dynamic anatomic features causing obstruction (ie, anatomic endotypes) in each child with small tonsils or Down syndrome will be superior to the currently recommended standard first line approach of AT. This novel approach may improve OSA outcomes and reduce the burden of unnecessary AT or secondary surgery for persistent OSA after an ineffective AT. To test this hypothesis, the investigators will study children aged 2 to 18 years with clinically small tonsils (Brodsky score 1+ or 2+ on a scale 1+ to 4+) OR Down syndrome.
Interventions
- PROCEDURE Adenotonsillectomy
- PROCEDURE Drug-induced sleep endoscopy directed surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2024-10-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154214
The ClinicalTrials.gov registry entry for NCT05154214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adenotonsillectomy is the first listed.
NCT05154214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05154214 about?
NCT05154214 is a clinical study titled "Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome". The purpose of this study is to prospectively compare the effectiveness of a novel personalized approach to the surgical treatment of obstructive sleep apnea (OSA) in children, drug induced sleep endoscopy (DISE) directed surgery versus the standard adenotonsillectomy (AT). This will also serve to t...
What is the current status of trial NCT05154214?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-11-09. Estimated completion is 2024-10-11.
What interventions are being tested in trial NCT05154214?
The interventions under investigation include: Adenotonsillectomy (PROCEDURE), Drug-induced sleep endoscopy directed surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05154214?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.